title: What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver.
authors.affiliation: Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Philip M
authors.initials: PM
authors.lastname: Brown
authors.affiliation: Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Yaron
authors.initials: Y
authors.lastname: Rotman
mesh_terms: D006801:Humans; D008099:Liver; D065626:Non-alcoholic Fatty Liver Disease; D012038:Regeneration
keywords: FATTY LIVER; LIVER REGENERATION; NONALCOHOLIC STEATOHEPATITIS